TrialJournal for immunotherapy of cancer2022

Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model.

Richard J Sové et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.